HighTower Advisors’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
Other funds holding EVH
RCM
EC
RSCM
EAM
HighTower Advisors's EVH Position: Q2 2024 in Review
HighTower Advisors sold out of Evolent Health (EVH) in Q2 2024, closing a stake of 70,211 shares — an estimated $2.31M sold.
HighTower Advisors first reported a position in EVH in Q3 2018 and held it in 15 quarters. The position peaked at $3.76M in Q4 2023. 243 funds tracked by Wall St. Rank hold EVH as of Q2 2024.
- HighTower Advisors reported no remaining Evolent Health position as of Q2 2024 after selling out during the quarter.
- HighTower Advisors sold 70,211 Evolent Health shares in Q2 2024, an estimated $2.31M.
- HighTower Advisors first reported a position in Evolent Health in Q3 2018 and held it in 15 quarters.
- HighTower Advisors's Evolent Health position peaked at $3.76M in Q4 2023.
- 243 funds tracked by Wall St. Rank held Evolent Health as of Q2 2024.
Based on HighTower Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.